How to Buy Sanofi Stock
Sanofi
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
Sanofi stock last closed at $54.95, up 2.29% from the previous day, and has increased 11.62% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.09 percentage points. Sanofi stock is currently +19.98% from its 52-week low of $45.80, and -8.59% from its 52-week high of $60.12.
As of Apr 30, 2025, there are 1.26B shares of SNY outstanding. The market cap of SNY is $138.82B. In the last 24 hours, 1.69M SNY shares were traded.
How to Buy Sanofi Stock
Not sure how to invest in Sanofi stock? Here's how.
- Figure out where to buy Sanofi stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Sanofi stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your method of payment and add your info.
- Analyze Sanofi stock: The Sanofi ticker symbol is SNY. Is Sanofi stock a good investment? Should you buy shares of SNY? How do SNY's underlying business fundamentals look? Do top analysts think Sanofi is a good buy? Why has SNY's stock price moved recently? (Hint: Our stock market research website can help you figure out if SNY is a good stock to buy).
- Execute your SNY purchase: Decide if you will purchase SNY shares at the current market price or use a limit order to purchase SNY shares at a specific price.
- Get the latest scoop on your investment in SNY: Create a watchlist to track your position in Sanofi stock.
Step 1: Figure out where to buy Sanofi stock
You will need a brokerage account to access the NASDAQ market and buy SNY stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal information so you are able to invest in SNY today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on one of the best stock apps, you need to deposit funds:
Watch this video walkthrough for more details depositing funds into your new investment account.
Step 4: Analyze Sanofi stock
Once you have selected the best place to buy Sanofi stock, it's important to evaluate their stock before you buy, so you truly comprehend the risk and upside.
Sanofi quick stats
Sanofi Due Diligence Score
WallStreetZen was designed to help everyday investors do better fundamental analysis in less time.
You can see all of the due diligence checks on SNY's stock page.
Is SNY stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge SNY's fair value.
Using relative valuations ratios:
- SNY could be undervalued based on its P/E ratio of 23.76x, relative to Drug Manufacturers - General industry P/E ratio of 54.95x
- SNY may be undervalued based on its P/B ratio of 1.72x, relative to Drug Manufacturers - General industry P/B ratio of 6.33x
- SNY may be undervalued based on its PEG ratio of 0.75x
You can do more valuation research on SNY's stock here.
SNY Financial Health Summary
Pros:
- There are more short-term assets than short-term liabilities on the SNY balance sheet.
- SNY's operating cash flow of $9.46B allows it to safely service it's debt of $18.65B.
- Total SNY debt is lower than 5 years ago, relative to shareholder equity.
- SNY earnings of $8.16B is not sufficient to cover its interest payments.
- There are more short-term assets than long-term liabilities on the SNY balance sheet.
Cons:
- SNY has a relatively high debt to equity ratio of 0.71.
- SNY profit margin has gone down from 13% to 12.6% in the past year.
Is it a good time to buy Sanofi stock, according to analysts?
Out of 1 Equities analysts who give recommendations on SNY, the consensus analyst rating on SNY is a Hold
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Sanofi stock forecast page.
SNY Technicals
SNY Growth Numbers
Last year, SNY earnings were $5.79B. During the past 5 year, SNY's earnings have gone up by 13.35% per year. This was faster than the Drug Manufacturers - General industry average of 2.95%.
Last year, SNY revenue was $46.13B. In the past 5 year, SNY's revenue has grown by 1.76% per year. This was slower than the Drug Manufacturers - General industry average of 9.56%.
Find out more about SNY's earnings and revenue performance here.
Are SNY executives and large shareholders buying or selling the stock?
In the past year, insiders at SNY have not bought or sold any shares.
Research more about who owns SNY stock here.
Can I rely on SNY as an income stream?
Sanofi pays a dividend of 3.71%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.24%. If you owned $1,000 worth of SNY stock, you would have been paid $37.08 in the past year.
Sanofi dividend payments have consistently grown over the past decade but have not remained stable.
Get more data about Sanofi dividend yield and history here.
SNY Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your SNY purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount, use a limit order.
Press the Open Trade button and eToro will execute your order.
If you need additional help with buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest scoop on your investment in SNY
Now that you own some SNY shares, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to track the latest developments regarding your SNY stock.
SNY Feed
How to Buy Stock in Sanofi
To summarize, here are the 6 steps you need to take to buy Sanofi stock right now:
- Figure out where to buy Sanofi stock
- Open a brokerage account
- Fund your brokerage account
- Analyze Sanofi stock
- Execute your SNY purchase
- Get the latest scoop on your investment in SNY
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Sanofi, add SNY to your watchlist by clicking the button below.
More Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.